Browse Drug Recalls
6,274 FDA drug safety recalls.
FDA Drug Recall Enforcement Database
Browse 6,274 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.
Drug Safety Recalls
Browse 6,274 FDA drug recalls.
| Date | Product | Reason | Class | Firm |
|---|---|---|---|---|
| May 18, 2017 | fentaNYL (as citrate) in 0.9% Sodium Chloride injectable,10 mcg per mL, Total... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | MAGNESIUM Sulfate added to 100 mL 0.9% Sodium Chloride injectable, 4g, Total ... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | fentaNYL (as citrate) in 0.9% Sodium Chloride injectable,10 mcg per mL, Total... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | morphine sulfate in 0.9% Sodium Chloride injectable, 1 mg per mL, Total Volum... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | ceFAZolin sodium added to 100 mL 0.9% Sodium Chloride injectable, 3g, Total ... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | PHENYLephrine HCL in 0.9% Sodium Chloride injectable, 10 mg (Final Concentrat... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 18, 2017 | fentaNYL (as citrate) in 100mL 0.9% Sodium Chloride injectable,20 mcg per mL,... | Lack of assurance of sterility: Product bags leaking at seam. | Class II | SCA Pharmaceuticals |
| May 15, 2017 | Milrinone Lactate in 5% Dextrose Injection, 20 mg/100 mL, 100 mL Single-Dose ... | Lack of assurance of sterility: customer complaints received for the presence of leaks. | Class II | Baxter Healthcare Corporation |
| May 15, 2017 | Fluconazole Injection, USP, 200 mg/100 mL (2mg/mL), 100 mL Single-Dose Intrav... | Lack of assurance of sterility: customer complaints received for the presence of leaks. | Class II | Baxter Healthcare Corporation |
| Apr 18, 2017 | PROCAINE HCL *5ML* SDV SULFITE FREE 1% INJ, Injection, 1%, RXxonly, 5mL Glass... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | QUAD MIX 50/30/1/0.2 5ML MDV (CALIF) MCG/MG/MG/MG/ML INJ, Injection, 50mcg/30... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | ALPHA LIPOIC ACID 25ML MDV 25MG/ML INJ, Injection, 25mg/mL, Rx only, 25 mL Gl... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | SODIUM CARBOXYM-CELL PF 0.5% OPHTH, opthalmic, 0.50%, Rx only, 10mL Glass/Mul... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | VITAMIN D3 IN OLIVE OIL SDV 100,000U/ML INJ, Injection, 150,000u/mL, Rx only,... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PGE1/PROCAINE 5ML MDV 20MCG/ML/0.1% INJ, Injection, 20mcg/ml 0.1%, Rx only, 5... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | VITAMIN D3 IN OLIVE OIL SDV 100,000U/ML INJ, Injection, 100,000u/mL, Rx only,... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PROCAINE HCL SDV 1% INJ, Injection, 1%, Rx only, packaged in 5mL and 50 mL Gl... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | HYDROXO-B12 5ML PBF MDV (CALIF) 10MG/ML INJ, Injection, 10mg/mL, RX only, 5mL... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 5.95/17.8572/0.6 5ML MDV MCG/MG/MG/ML INJ, Injection, 5.95mcg/17.85mg... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | 5-MTHF 10ML MDV (CALIF) 5MG/ML INJ, Injection, 5mg/mL, Rx only, 10mLGlass/Mul... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PAPAVERINE/PHENT 5ML MDV 30/1MG/ML INJ, Injection, 30mg/1mg/mL, Rx only, 5mL ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | 5-MTHF *10ML* MDV 5MG/ML INJ, Injection, 5mg/mL, Rx only, 10mL Glass/Multiple... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TESTOST CYP SESAME OIL 5ML MDV 100MG/ML INJ, Injection, 100mg/mL, Rx only, 5 ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | HYDROXO-B12 1ML SDV 10MG/ML INJ, Injection, 10mg/mL, Rx only, 1 mL glass/ Si... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 16.7/4/0.27 5ML MDV MCG/MG/MG/ML INJ, Injection, 16.7mcg/4mg/0.27mg/m... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | 5-MTHF SDV 5MG/ML INJ, Injection, 5mg/mL, Rx only, packaged in 1 mL, 2 mL, 5 ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 5.88/17.65/0.588 5ML MDV MCG/MG/MG/ML INJ, , Injection, 5.88mcg/17.65... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 30/30/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 30mcg/30mg/1mg/mL, Rx on... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | HCG *10ML* MDV 500U/ML INJ, Injection, 500u/mL, Rx only, 10 mL Glass/Multiple... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PGE1/PROCAINE 5ML MDV 40MCG/ML/0.1% INJ, Injection, 40mcg/mL, 0.1%, Rx only, ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | SOD PHENYLBUTYRATE SDV 30ML (CALIF or NEZ-CALIF) 200MG/ML INJ, Injection, 200... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | METHYL-B12 *10ML* MDV 5MG/ML INJ, Injection, 5mg/mL, Rx only, 10 mL Glass/Mul... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PYRIDOXAL-5-PHOS 10ML MDV 100MG/ML INJ, Injection, 100mg/mL, Rx only, 10mL Gl... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TESTOST AQ MDV 50MG/ML INJ, Injection, 50mg/mL, Rx only, packaged in 5mL and... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PGE1/PAP 10/30 5ML MDV MCG/MG/ML INJ, Injection, 10mg/30mg/mL, Rx only, 5mL ... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | QUAD MIX 1/30/0.5/0.1 5ML MDV MCG/MG/MG/MG/ML INJ, Injection, 1mcg/30mg/0.5mg... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 20/20/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 20mcg/20mg/1mg/mL, Rx on... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | HYDROXO-B12 INH PF GV 5MG/ML SOLN, Inhalation Solution, 5mg/mL, Rx only, 5 m... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | 5-MTHF 10ML SDV (CALIF) 5MG/ML INJ, Injection 5mg/mL, Rx only, 10mL Glass /Si... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PROCAINE HCL 50ML MDV (CALIF) 1% INJ, Injection, 1%, Rx only, 50mL Glass/Mul... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 10/30/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 10mcg/30mg/1mg/mL, Rx o... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 10/15/2.5 5ML MDV MCG/MG/MG/ML INJ, Injection, 10mcg/15mg/2.5mg/mL, R... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 11.8/17.6/0.59 5ML MDV MCG/MG/MG/ML INJ, Injection, 11.8mcg/17.6mg/0.... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | HYDROXO-B12 *1ML* SDV 1MG/ML INJ, Injection, 1mg/mL, Rx only, 1 mL Glass/Sing... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | HYDROXO-B12 5ML PBF MDV 1MG/ML INJ, Injection, 1mg/ml, Rx only, packaged in 5... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | CYANOCOBALAMIN 10ML MDV 1MG/ML INJ, Injection, 1mg/mL, Rx only, 10mL Glass/Mu... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | ATROPINE SULFATE 0.01% OPHTH, Ophthalmic, 0.01%, Rx only, 15 mL Glass /Multip... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | PYRIDOXAL-5-PHOS 5ML MDV 50MG/ML INJ, 50mg/mL, Rx only, 5mL Glass/Multiple Do... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | VITAMIN B COMPLEX 1ML SDV NA INJ, Injection, 100mg/2mg/2mg/2mg/100mg/mL, Rx o... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
| Apr 18, 2017 | TRI MIX 20/30/1 5ML MDV MCG/MG/MG/ML INJ, Injection, 20mcg/30mg/1mg/mL, Rx on... | Lack of Assurance of Sterility: The firm is recalling sterile compounded drugs within expiry due ... | Class II | Key Pharmacy and Compounding Center |
Frequently Asked Questions
When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.
The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.
Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.